Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Lindsay Machen, Reza Razeghinejad & Jonathan S. Myers. (2020) Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opinion on Pharmacotherapy 21:10, pages 1269-1282.
Read now
Read now
Romeo Altafini, Maria-Luise Scherzer, Douglas A Hubatsch & Paolo Frezzotti. (2015) Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study. Clinical Ophthalmology 9, pages 2263-2270.
Read now
Read now
Yoshie Shimizu, Shunsuke Nakakura, Makiko Nishiyama, Hitoshi Tabuchi & Yoshiaki Kiuchi. (2015) Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog. Clinical Ophthalmology 9, pages 475-482.
Read now
Read now
Keiji Yoshikawa, Jun Kozaki & Hidetaka Maeda. (2014) Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 389-399.
Read now
Read now
Mikio Nagayama, Toru Nakajima & Junji Ono. (2014) Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 219-228.
Read now
Read now
Masayuki Nakajima, Naoki Iwasaki & Masaki Adachi. (2014) Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 149-156.
Read now
Read now